| __timestamp | Alkermes plc | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 7753000 | 4733600000 |
| Thursday, January 1, 2015 | 4019000 | 4796400000 |
| Friday, January 1, 2016 | 2301000 | 5243900000 |
| Sunday, January 1, 2017 | 7232000 | 5281800000 |
| Monday, January 1, 2018 | 68895000 | 5051200000 |
| Tuesday, January 1, 2019 | 52816000 | 5595000000 |
| Wednesday, January 1, 2020 | 1946000 | 6085700000 |
| Friday, January 1, 2021 | 1020000 | 7025900000 |
| Saturday, January 1, 2022 | 393842000 | 7190800000 |
| Sunday, January 1, 2023 | 270806000 | 9313400000 |
| Monday, January 1, 2024 | 245326000 | 14271000000 |
Data in motion
In the competitive world of pharmaceuticals, innovation is key. Eli Lilly and Company and Alkermes plc are two giants in the industry, each with a unique approach to research and development (R&D). Over the past decade, Eli Lilly has consistently outpaced Alkermes in R&D spending, investing nearly 60 times more on average. In 2023, Eli Lilly's R&D expenses reached a staggering $9.3 billion, marking a 97% increase from 2014. In contrast, Alkermes' investment peaked at $393 million in 2022, a significant rise from its 2014 figure but still a fraction of Eli Lilly's commitment.
This disparity highlights Eli Lilly's aggressive strategy to lead in innovation, while Alkermes focuses on more targeted investments. As the pharmaceutical landscape evolves, these investment patterns will shape the future of drug development and patient care.
Comparing Innovation Spending: Eli Lilly and Company and Novo Nordisk A/S
Research and Development Investment: Eli Lilly and Company vs argenx SE
Eli Lilly and Company or Halozyme Therapeutics, Inc.: Who Invests More in Innovation?
R&D Insights: How Eli Lilly and Company and Verona Pharma plc Allocate Funds
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Eli Lilly and Company or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Eli Lilly and Company vs Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and MiMedx Group, Inc.
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
Research and Development Investment: Corcept Therapeutics Incorporated vs Alkermes plc